Evidence map›Paper›PMID 33020988›Full record

ReviewJournal of internal medicine2021

The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review.

Andrew Y Chang, Mark R Cullen, Robert A Harrington, Michele Barry

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 4 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 4 syntheses or guidelines pooled it, 222 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. A systematic review of COVID-19's impact on pregnancy outcomes.Annals of medicine and surgery (2012) · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Challenges to quality in contemporary, hybrid general practice a multi-site longitudinal case study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2025
    Article
  19. Article
  20. New Diagnoses of Juvenile Idiopathic Arthritis Early in the COVID-19 Pandemic: Analysis of a Large United States Commercial Insurance Database.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2025
    Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Andrew Y ChangFrom the, Division of Cardiovascular Medicine, Stanford University, Stanford, CA, USA.ORCID 0000-0002-3009-6678
Mark R CullenDepartment of Medicine, Stanford University, Stanford, CA, USA.
Robert A HarringtonDepartment of Medicine, Stanford University, Stanford, CA, USA.
Michele BarryDepartment of Medicine, Stanford University, Stanford, CA, USA.
Stanford Health Care · USCardiovascular Institute of the South · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic affecting all levels of health systems. This includes the care of patients with noncommunicable diseases (NCDs) who bear a disproportionate burden of both COVID-19 itself and the public health measures enacted to combat it. In this review, we summarize major COVID-19-related considerations for NCD patients and their care providers, focusing on cardiovascular, pulmonary, renal, haematologic, oncologic, traumatic, obstetric/gynaecologic, operative, psychiatric, rheumatologic/immunologic, neurologic, gastrointestinal, ophthalmologic and endocrine disorders. Additionally, we offer a general framework for categorizing the pandemic's disruptions by disease-specific factors, direct health system factors and indirect health system factors. We also provide references to major NCD medical specialty professional society statements and guidelines on COVID-19. COVID-19 and its control policies have already resulted in major disruptions to the screening, treatment and surveillance of NCD patients. In addition, it differentially impacts those with pre-existing NCDs and may lead to de novo NCD sequelae. Likely, there will be long-term effects from this pandemic that will continue to affect practitioners and patients in this field for years to come.

Indexed as

Communicable Disease ControlCOVID-19Noncommunicable DiseasesPatient Care ManagementHumansOrganizational InnovationPublic HealthSARS-CoV-2chronic diseasesCOVID-19noncommunicable diseasespublic health

Identifiers

PMID33020988
PMCPMC7675448
OpenAlexW3090113966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.